Chapter 9: Principles of Infectious Disease and Epidemiology

Disease Terminology

Understanding the language of infectious disease is essential for effective communication in microbiology and epidemiology.

• Pathogen: A microorganism capable of causing disease.

• Infection: The invasion and multiplication of a pathogen in a host organism.

• Disease: A condition in which normal body functions are disrupted due to infection.

• Etiological Agent: The causative agent of a disease (often a specific microbe).

• Reservoir: The natural habitat where a pathogen lives and multiplies.

• Carrier: An individual who harbors a pathogen without showing symptoms but can transmit it to others.

Mode of Transmission

Pathogens can be transmitted through various routes, influencing the spread and control of infectious diseases.

• Direct Transmission: Physical contact between infected and susceptible individuals (e.g., touching, kissing).

• Indirect Transmission: Involves intermediaries such as fomites (inanimate objects), vectors (insects), or airborne particles.

• Vehicle Transmission: Spread through contaminated food, water, or air.

• Vector Transmission: Transmission via living organisms, typically arthropods (e.g., mosquitoes, ticks).

Five General Stages of Disease Occur During Infections

Infectious diseases typically progress through distinct stages:

1. Incubation Period: Time between pathogen entry and appearance of symptoms.

2. Prodromal Phase: Early, mild symptoms appear.

3. Acute Phase: Disease symptoms are most severe.

4. Period of Decline: Symptoms subside as the immune system overcomes the pathogen.

5. Convalescent Phase: Recovery and return to normal health.

The Epidemiological Triangle Links Host, Etiological Agent, and Environment

The epidemiological triangle is a model for understanding the factors involved in disease spread.

• Host: The organism harboring the disease.

• Etiological Agent: The microbe causing the disease.

• Environment: External factors that affect disease transmission (e.g., climate, sanitation).

Example: Malaria transmission depends on the presence of Plasmodium (agent), humans (host), and mosquitoes plus suitable climate (environment).

Healthcare-Acquired Infections (HAIs)

HAIs are infections acquired in healthcare settings, posing significant risks and costs.

• Common HAIs: Urinary tract infections, surgical site infections, pneumonia, bloodstream infections.

• Causes: Invasive procedures, antibiotic resistance, immunocompromised patients.

• Prevention: Hand hygiene, sterilization, infection control protocols.

Surveillance of Emerging and Reemerging Diseases

Monitoring disease patterns helps identify outbreaks and "hot spots"—regions with high incidence of emerging diseases.

• Emerging Diseases: Newly identified or increasing in incidence (e.g., COVID-19).

• Reemerging Diseases: Previously controlled diseases that are resurging (e.g., measles).

• Surveillance Methods: Epidemiological mapping, reporting systems, laboratory diagnostics.

Chapter 10: Host-Microbe Interactions and Pathogenesis

Host–Microbe Interactions Are Not Always Harmful

Not all interactions between hosts and microbes result in disease; many are beneficial or neutral.

• Commensalism: Microbe benefits, host is unaffected.

• Mutualism: Both host and microbe benefit (e.g., gut microbiota synthesizing vitamins).

• Parasitism: Microbe benefits at the host's expense (pathogenic relationship).

The Dosage of Pathogen and Toxin Exposure Affects Host Health Outcomes

• Infectious Dose (ID50): The number of microbes required to cause infection in 50% of exposed hosts.

• Lethal Dose (LD50): The amount of toxin required to kill 50% of exposed hosts.

• Lower ID50 or LD50 indicates higher virulence.

Toxins are Major Virulence Factors

• Exotoxins: Proteins secreted by bacteria that cause damage to host tissues (e.g., botulinum toxin).

• Endotoxins: Lipopolysaccharide (LPS) components of Gram-negative bacterial outer membranes; released upon cell death.

Five Steps to Infection

1. Entry: Pathogen enters the host (e.g., via respiratory tract).

2. Adhesion: Pathogen attaches to host cells.

3. Invasion: Pathogen invades tissues and obtains nutrients.

4. Evading Host Defenses: Pathogen avoids immune detection.

5. Exit: Pathogen leaves the host to infect new hosts.

Portals of Entry and Exit

• Portals of Entry: Mucous membranes, skin, respiratory tract, gastrointestinal tract, urogenital tract.

• Portals of Exit: Routes by which pathogens leave the host (e.g., respiratory droplets, feces, urine, blood).

Hiding From Host Immune Defenses

• Antigenic Variation: Pathogens alter surface proteins to evade immune detection.

• Intracellular Lifestyle: Some pathogens survive inside host cells (e.g., Mycobacterium tuberculosis).

• Biofilm Formation: Communities of microbes encased in protective matrices.

Biosafety Levels (BSL)

Biosafety levels define laboratory practices and containment for handling pathogens.

Chapter 11: Innate Immunity

Immune Responses: Innate vs. Adaptive

The immune system is divided into innate (nonspecific) and adaptive (specific) responses.

• Innate Immunity: Immediate, non-specific defense present at birth.

• Adaptive Immunity: Specific, acquired defense that develops after exposure to antigens.

First-Line Defenses: Preventing Pathogen Entry

• Mechanical Barriers: Physical removal of microbes (e.g., cilia, mucus, tears).

• Chemical Barriers: Substances that inhibit or destroy pathogens (e.g., lysozyme, stomach acid).

• Physical Barriers: Structures that block pathogen entry (e.g., skin, mucous membranes).

Primary and Secondary Lymphoid Tissues

• Primary Lymphoid Tissues: Sites of immune cell production and maturation (bone marrow, thymus).

• Secondary Lymphoid Tissues: Sites where immune responses are initiated (lymph nodes, spleen, tonsils).

Key Immune Cells

• Neutrophils: Most abundant white blood cells; phagocytose and destroy microbes.

• Basophils: Release histamine; involved in allergic responses.

• Monocytes/Macrophages: Phagocytic cells that engulf pathogens and present antigens.

• Dendritic Cells: Antigen-presenting cells that activate adaptive immunity.

Complement Cascades

The complement system is a group of proteins that enhance immune responses.

• Activation Pathways: Classical, alternative, and lectin pathways.

• Outcomes: Opsonization (enhanced phagocytosis), inflammation, and cell lysis.

Equation:

Inflammation and Fever

• Inflammation: Localized response to injury or infection; characterized by redness, heat, swelling, and pain.

• Chronic Inflammation: Prolonged inflammation that can damage tissues.

• Fever: Systemic increase in body temperature; enhances immune function and inhibits pathogen growth.

Chapter 12: Adaptive Immunity

General Steps in an Adaptive Immune Response

1. Antigen Presentation: Antigen-presenting cells display antigens to T cells.

2. Lymphocyte Activation: T and B cells are activated by antigen exposure.

3. Lymphocyte Proliferation and Differentiation: Activated cells multiply and specialize.

4. Antigen Elimination and Memory: Effector cells eliminate antigens; memory cells persist for future responses.

Immunogenicity and Antigen Features

• Immunogenicity: The ability of a substance to provoke an immune response.

• Antigen: Any molecule recognized by the immune system as foreign.

• Epitope: The specific part of an antigen recognized by antibodies or T cells.

T Helper Cells

• CD4+ T Cells: Coordinate immune responses by activating other immune cells.

• Subtypes: Th1 (cell-mediated immunity), Th2 (humoral immunity), Th17 (inflammation).

T Cells and B Cells are Screened for Self-Tolerance

• Self-Tolerance: The ability of immune cells to avoid attacking the body's own tissues.

• Clonal Deletion: Removal of self-reactive lymphocytes during development.

MHC Molecules and Antigen Presentation

• MHC I: Present intracellular antigens to cytotoxic T cells (CD8+).

• MHC II: Present extracellular antigens to helper T cells (CD4+).

Stages of T Cell Activation and Proliferation

• Stage 2: T cells are activated by antigen-presenting cells in lymphatic tissues.

• Stage 3: Activated T cells proliferate and differentiate into effector and memory cells.

Antibody Structure and Isotypes

• Antibody: Y-shaped protein produced by B cells; binds specific antigens.

• Structure: Two heavy chains, two light chains, variable and constant regions.

Humoral Immunity: Natural and Artificial, Passive and Active

• Active Immunity: Host produces antibodies after exposure to antigen (natural infection or vaccination).

• Passive Immunity: Host receives pre-formed antibodies (maternal antibodies, antibody therapy).

• Natural Immunity: Acquired through natural exposure.

• Artificial Immunity: Acquired through medical intervention (e.g., vaccines, immunoglobulin therapy).